Sebagai salah satu obat yang paling banyak diresepkan, penggunaan penghambat pompa

been known to cause gastrointestinal structural changes. One of which is hyperplasia and hypertrophy of ECL cell hyperplasia is one of the risk factors associated with several gastric neoplasms. This study attempted to clarify the link between PPI use and ECL cell hyperplasia among patients with long and short-term PPI use. Method: records. Clinical data included age, sex, and history of PPI were recorded. Tissue slides of the polyp samples